Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients
ConditionAcne
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-25
SponsorNational Skin Centre
About this trial
This study aims to uncover the specific immunopathology, microbiome and pathophysiology of acne vulgaris in people living in a tropical climate such as Singapore. This is a largely unexplored population in terms of acne pathogenesis, and will lead to population-specific interventions for the management of acne vulgaris.
Eligibility criteria
Qualifiers
Mild facial acne vulgaris defined as Investigator's Global Assessment (IGA) of 2, or
Moderate facial acne vulgaris defined as IGA score of 3, or
Severe facial acne vulgaris defined as IGA score of 4, or
Healthy volunteers without acne defined as IGA score of 0.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 4 trial groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov